Financhill
Back

Quest Diagnostics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
50

DGX
Quest Diagnostics

Last Price:
140.78
Seasonality Move:
3.29%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
41.11
Seasonality Move:
12.29%
Sell
50
Quest Diagnostics (DGX) is a Sell

Is Quest Diagnostics a Buy, Sell or Hold?

  • The current Quest Diagnostics [DGX] share price is $139.16. The Score for DGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • DGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $40.97. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DGX Stock Price Chart

What is Quest Diagnostics's stock price today?

  • The Quest Diagnostics share price today is $139.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DGX is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $40.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight selling pressure.

DGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.19 Buy
Relative Strength Index (14 RSI): 60 Buy
Chaikin Money Flow: -230197 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (129.72 - 138.74) Buy
Bollinger Bands (100): (126.53 - 136.51) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.41 Sell
Relative Strength Index (14 RSI): 35.08 Sell
Chaikin Money Flow: -198670 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.06 - 46.28) Sell
Bollinger Bands (100): (43.39 - 49.39) Sell

DGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 137.83 Buy
20-day SMA: 135.48 Buy
50-day SMA: 131.91 Buy
200-day SMA: 131.04 Buy
8-day EMA: 138.18 Buy
20-day EMA: 136.05 Buy
50-day EMA: 133.25 Buy
200-day EMA: 132.58 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.66 Sell
20-day SMA: 42.86 Sell
50-day SMA: 45.82 Sell
200-day SMA: 42.07 Sell
8-day EMA: 41.62 Sell
20-day EMA: 42.96 Sell
50-day EMA: 44.73 Sell
200-day EMA: 44.3 Sell

Quest Diagnostics Earnings Growth & DGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.19 per share, an increase this year of $0.11 per share, and an increase next year of $0.63 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.

Quest Diagnostics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):